Postscript: What Is the Role of Dendritic Cells in the Pathogenesis of Human Cytomegalovirus in Immunocompetent and Immunocompromised Hosts?

  • Yechiel Becker
Part of the Frontiers of Virology book series (FRVIROLOGY, volume 2)

Summary

The information concerning the complications that human cytomegalovirus (HCMV) is capable of inflicting in immunosuppressed people (organ transplant patients and acquired immune deficiency, AIDS, patients) is described in detail in numerous chapters of this book. Yet, the responses of immune cells in the protection against HMCV infections and the role of the dendritic cell system in the defense against virus reactivations is not fully known. From the research on the role of dendritic cells in the cellular defense against Herpes simplex virus-1, it is possible to suggest that further studies on the effect of immunosuppressive drugs (cyclosporin A, cyclophosphamide, FK506) and their inhibitory effect on dendritic cells may lead to differentiation between the antiviral dendritic cells and the dendritic cells involved in graft rejection. Drugs which do not prevent the antiviral activity of dendritic cells but preserve the dendritic cells capable of anti-HMCV activity, while inhibiting the dendritic cells involved in graft rejection, might be the immunosuppressive drugs of choice.

Keywords

Hepatitis Dust Lymphoma Leukemia Pneumonia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Austyn JM (1987) Lymphoid dendritic cells. Immunology 62: 161–170PubMedGoogle Scholar
  2. 2.
    Austyn JM (1989) Antigen presenting cells. IRL Press, New YorkGoogle Scholar
  3. 3.
    Beck S, Barrel BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331: 269–272CrossRefPubMedGoogle Scholar
  4. 4.
    Fujinami RS, Nelson JA, Walker L, Oldstone MB (1988) Sequence homology and immunologic cross reactivity of human cytomegalovirus with HLA-DR beta chain: a means of graft rejection and immunosuppression. J Virol 62: 100–105PubMedGoogle Scholar
  5. 5.
    Holt PG, Schon-Hegrad MA, Oliver J, Holt BJ, McMenamin PG (1990) A contiguous network of dendritic antigen-presenting cells within the respiratory epithelium. Int Arch Allergy Appl Immunol 91: 155–159CrossRefPubMedGoogle Scholar
  6. 6.
    Katz SI, Tamaki K, Sachs DH (1979) Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282: 324–326CrossRefPubMedGoogle Scholar
  7. 7.
    Otani T, Mori K (1987) The effects of ultraviolet irradiation of the skin on HSV infections: alteration in immune function mediated by epidermal cells and in the course of infection. Arch Virol 96: 1–15CrossRefPubMedGoogle Scholar
  8. 8.
    Pollard AM, Lipscomb MF (1990) Characterization of murine lung dendritic cells: similarities to Langerhans cells and thymic dendritic cells. J Exp Med 172: 159–167CrossRefPubMedGoogle Scholar
  9. 9.
    Schon-Hegrad MA, Oliver J, McMenamin PG, Holt PG (1991) Studies on the density, distribution and surface phenotype of intraepithelial class II major histocompatbility. J Exp Med 173: 1345–1356CrossRefPubMedGoogle Scholar
  10. 10.
    Serti K, Takemura T, Tschachler E, Ferrans VJ, Kaliner MA, Shevach EM (1986) Dendritic cells with antigen-presenting capability reside in airway epithelium, lung parenchyma and visceral pleura. J Exp Med 163: 436–451CrossRefGoogle Scholar
  11. 11.
    Sprecher E, Becker Y (1986) Skin Langerhans cells play an essential role in the defense against HSV-1 infection. Arch Virol 91: 341–349CrossRefPubMedGoogle Scholar
  12. 12.
    Sprecher E, Becker Y (1987) Herpes simplex virus type 1 pathogenicity in foot pad and ear skin of mice depends on Langerhans cell density, mouse genetics and virus strain. J Virol 61: 2515–2522PubMedGoogle Scholar
  13. 13.
    Sprecher E, Becker Y (1988) Role of epidermal Langerhans cells in viral infections. Arch Virol 103: 1–14CrossRefPubMedGoogle Scholar
  14. 14.
    Sprecher E, Becker Y (1989) Langerhans cell number and activity in the skin and lymph nodes determines HSV-1 pathogenicity. Arch Virol 107: 191–205CrossRefPubMedGoogle Scholar
  15. 15.
    Sprecher E, Becker Y (1991) Dendritic cells in the epidermis and the lymph nodes — a review. In: Becker Y (ed) Skin Langerhans (dendritic) cells in virus infections and AIDS. Kluwer, Boston, pp 3–23CrossRefGoogle Scholar
  16. 16.
    Sprecher E, Becker Y (1992a) Role of dendritic cells in disease states. In preparationGoogle Scholar
  17. 17.
    Sprecher E, Becker Y (1992b) Detection of IL-lß, TNFa and IL-6 gene transcription by the polymerase chain reaction in keratinocytes, Langerhans cells and peritoneal exudate cells during infection with Herpes simplex virus-1. Arch Virol (In press)Google Scholar
  18. 18.
    Williams NA, Blyth WA, Hill TJ (1991) Langerhans cells and recurrent infection with Herpes simplex virus. In: Becker Y (ed) Skin Langerhans (dendritic) cells in virus infections and AIDS. Kluwer, Boston, pp 185–201CrossRefGoogle Scholar
  19. 19.
    Xia W, Schneeberger EE, McCarthy K, Kradin RL (1991) Accessory cells of the lung. II. Ia + pulmonary cells display cell surface antigen heterogeneity. Am J Respir Cell Mol Biol 5: 276–283PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • Yechiel Becker
    • 1
  1. 1.Department of Molecular Virology, Faculty of MedicineThe Hebrew University of JerusalemJerusalemIsrael

Personalised recommendations